# Double-Blind Randomized Cross-Over Trial Comparing Metabolic Effects of Candesartan, Hydrochlorothiazide and Placebo

> **NCT00282178** · PHASE2 · COMPLETED · sponsor: **Umeå University** · enrollment: 26 (actual)

## Conditions studied

- Hypertension
- Obesity

## Interventions

- **DRUG:** Hydrochlorothiazide
- **DRUG:** Placebo
- **DRUG:** Candesartan

## Key facts

- **NCT ID:** NCT00282178
- **Lead sponsor:** Umeå University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-04
- **Primary completion:** 2006-03
- **Final completion:** 2006-04
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2008-10-16

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00282178

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00282178, "Double-Blind Randomized Cross-Over Trial Comparing Metabolic Effects of Candesartan, Hydrochlorothiazide and Placebo". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00282178. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*